134 related articles for article (PubMed ID: 20883026)
1. An o-aminoanilide analogue of 1α,25-dihydroxyvitamin D(3) functions as a strong vitamin D receptor antagonist.
Lamblin M; Spingarn R; Wang TT; Burger MC; Dabbas B; Moitessier N; White JH; Gleason JL
J Med Chem; 2010 Oct; 53(20):7461-5. PubMed ID: 20883026
[TBL] [Abstract][Full Text] [Related]
2. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of calcioic acid.
Yu OB; Mutchie TR; Di Milo ES; Arnold LA
Steroids; 2020 Feb; 154():108536. PubMed ID: 31704333
[TBL] [Abstract][Full Text] [Related]
4. 1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
Ishizuka S; Kurihara N; Hiruma Y; Miura D; Namekawa J; Tamura A; Kato-Nakamura Y; Nakano Y; Takenouchi K; Hashimoto Y; Nagasawa K; Roodman GD
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):269-77. PubMed ID: 18501591
[TBL] [Abstract][Full Text] [Related]
5. Dramatic enhancement of antagonistic activity on vitamin D receptor: a double functionalization of 1alpha-hydroxyvitamin D3 26,23-lactones.
Saito N; Saito H; Anzai M; Yoshida A; Fujishima T; Takenouchi K; Miura D; Ishizuka S; Takayama H; Kittaka A
Org Lett; 2003 Dec; 5(25):4859-62. PubMed ID: 14653692
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3.
Laverny G; Penna G; Uskokovic M; Marczak S; Maehr H; Jankowski P; Ceailles C; Vouros P; Smith B; Robinson M; Reddy GS; Adorini L
J Med Chem; 2009 Apr; 52(8):2204-13. PubMed ID: 19309155
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonist.
Cho K; Uneuchi F; Kato-Nakamura Y; Namekawa J; Ishizuka S; Takenouchi K; Nagasawa K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4287-90. PubMed ID: 18635349
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation.
Sicinski RR; Glebocka A; Plum LA; DeLuca HF
J Med Chem; 2007 Nov; 50(24):6154-64. PubMed ID: 17960924
[TBL] [Abstract][Full Text] [Related]
9. Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
Petersen KS; Dolan PM; Kensler TW; Peleg S; Posner GH
J Med Chem; 2007 Nov; 50(23):5824-32. PubMed ID: 17924616
[TBL] [Abstract][Full Text] [Related]
10. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
Pérez-García X; Rumbo A; Larriba MJ; Ordóñez P; Muñoz A; Mouriño A
Org Lett; 2003 Oct; 5(22):4033-6. PubMed ID: 14572242
[TBL] [Abstract][Full Text] [Related]
11. Remarkable effect of 2[small alpha]-modification on the VDR antagonistic activity of 1small alpha-hydroxyvitamin D3-26,23-lactones.
Saito N; Matsunaga T; Fujishima T; Anzai M; Saito H; Takenouchi K; Miura D; Ishizuka S; Takayama H; Kittaka A
Org Biomol Chem; 2003 Dec; 1(24):4396-402. PubMed ID: 14685312
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
14. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
Yamamoto K; Inaba Y; Yoshimoto N; Choi M; DeLuca HF; Yamada S
J Med Chem; 2007 Mar; 50(5):932-9. PubMed ID: 17298045
[TBL] [Abstract][Full Text] [Related]
15. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J
Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708
[TBL] [Abstract][Full Text] [Related]
16. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
Peräkylä M; Molnár F; Carlberg C
Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
[TBL] [Abstract][Full Text] [Related]
17. Potent antagonist for the vitamin D receptor: vitamin D analogues with simple side chain structure.
Sakamaki Y; Inaba Y; Yoshimoto N; Yamamoto K
J Med Chem; 2010 Aug; 53(15):5813-26. PubMed ID: 20608741
[TBL] [Abstract][Full Text] [Related]
18. Structural Analysis of VDR Complex with ZK168281 Antagonist.
Belorusova AY; Chalhoub S; Rovito D; Rochel N
J Med Chem; 2020 Sep; 63(17):9457-9463. PubMed ID: 32787090
[TBL] [Abstract][Full Text] [Related]
19. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
